SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4twf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MIC_A_DVAA6_0 (GRAMICIDIN A)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	3 / 3	ALA A 75 VAL A 73 TRP A 43	None	0.83A	1micA-4twfA: undetectable 1micB-4twfA: undetectable	1micA-4twfA: 4.08 1micB-4twfA: 4.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P16_A_GG2A298_2 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	3 / 3	ARG A 231 GLU A 226 GLN A 298	None	1.04A	2p16A-4twfA: undetectable	2p16A-4twfA: 19.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2YOE_C_FL7C1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 8	ILE A 39 VAL A 73 SER A 84 THR A 87 TYR A 102	None	0.42A	2yoeB-4twfA: 34.3 2yoeC-4twfA: 34.4	2yoeB-4twfA: 99.35 2yoeC-4twfA: 99.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IJD_A_C2FA314_0 (UNCHARACTERIZED PROTEIN)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 12	VAL A 35 GLY A 108 LEU A 107 ILE A 39 ILE A 191	None	1.04A	3ijdA-4twfA: undetectable	3ijdA-4twfA: 22.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_A_ACHA323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.70A	3rqwA-4twfA: 33.0 3rqwB-4twfA: 33.0	3rqwA-4twfA: 99.35 3rqwB-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_B_ACHB323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.68A	3rqwB-4twfA: 33.0 3rqwC-4twfA: 33.0	3rqwB-4twfA: 99.35 3rqwC-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_C_ACHC323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 8	GLU A 77 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.67A	3rqwC-4twfA: 33.0 3rqwD-4twfA: 33.0	3rqwC-4twfA: 99.35 3rqwD-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_D_ACHD323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.67A	3rqwD-4twfA: 33.0 3rqwE-4twfA: 33.0	3rqwD-4twfA: 99.35 3rqwE-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_E_ACHE323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.67A	3rqwA-4twfA: 33.0 3rqwE-4twfA: 33.0	3rqwA-4twfA: 99.35 3rqwE-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_F_ACHF323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.68A	3rqwF-4twfA: 33.0 3rqwG-4twfA: 33.0	3rqwF-4twfA: 99.35 3rqwG-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_G_ACHG323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.67A	3rqwG-4twfA: 33.0 3rqwH-4twfA: 33.0	3rqwG-4twfA: 99.35 3rqwH-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_H_ACHH323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.66A	3rqwH-4twfA: 33.0 3rqwI-4twfA: 33.0	3rqwH-4twfA: 99.35 3rqwI-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_I_ACHI323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 8	ILE A 79 GLU A 131 TYR A 175 PHE A 188	None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.60A	3rqwI-4twfA: 33.0 3rqwJ-4twfA: 33.0	3rqwI-4twfA: 99.35 3rqwJ-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQW_J_ACHJ323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 8	GLU A 77 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.68A	3rqwF-4twfA: 33.0 3rqwJ-4twfA: 33.0	3rqwF-4twfA: 99.35 3rqwJ-4twfA: 99.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U7S_A_017A201_2 (POL POLYPROTEIN)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	ALA A 104 ILE A 63 ILE A 101 PRO A 74 LEU A 76	None	1.20A	3u7sB-4twfA: undetectable	3u7sB-4twfA: 14.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_A_ZPCA1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 7	GLU A 77 ILE A 79 GLU A 131 PHE A 133 TYR A 175	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-4.5A) BR7 A 401 (-3.9A)	0.40A	4a97A-4twfA: 33.7	4a97A-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_A_ZPCA1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 7	ILE A 79 GLU A 131 TYR A 175 VAL A 181	None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) None	1.10A	4a97A-4twfA: 33.7	4a97A-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_A_ZPCA1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 7	PHE A 19 TYR A 38 VAL A 40 ARG A 91 ILE A 101	None	0.48A	4a97E-4twfA: 33.7	4a97E-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_A_ZPCA1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 7	PHE A 19 VAL A 40 ARG A 91 ASN A 103	None	0.91A	4a97E-4twfA: 33.7	4a97E-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_A_ZPCA1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 7	TYR A 38 VAL A 40 ARG A 91 GLU A 150	None	0.72A	4a97E-4twfA: 33.7	4a97E-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_D_ZPCD1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 8	PHE A 19 TYR A 38 VAL A 40 ARG A 91 MET A 93 ILE A 101	None	0.55A	4a97C-4twfA: 33.8	4a97C-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_D_ZPCD1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 8	PHE A 19 VAL A 40 ARG A 91 MET A 93 ASN A 103	None	0.90A	4a97C-4twfA: 33.8	4a97C-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_D_ZPCD1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 7	GLU A 77 ILE A 79 GLU A 131 PHE A 133 TYR A 175	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-4.5A) BR7 A 401 (-3.9A)	0.54A	4a97D-4twfA: 33.6	4a97D-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_E_ZPCE1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 8	PHE A 19 TYR A 38 VAL A 40 ARG A 91 MET A 93 ILE A 101	None	0.45A	4a97D-4twfA: 33.6	4a97D-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_E_ZPCE1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 8	PHE A 19 VAL A 40 ARG A 91 MET A 93 ASN A 103	None	0.85A	4a97D-4twfA: 33.6	4a97D-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_E_ZPCE1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 8	TYR A 38 ARG A 91 MET A 93 GLU A 150	None	0.91A	4a97D-4twfA: 33.6	4a97D-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_E_ZPCE1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 6	GLU A 131 PHE A 133 TYR A 175 PHE A 188	BR7 A 401 (-4.1A) BR7 A 401 (-4.5A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.55A	4a97E-4twfA: 33.7	4a97E-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_F_ZPCF1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 12	PHE A 19 TYR A 38 ARG A 91 MET A 93 ILE A 101	None	0.49A	4a97F-4twfA: 33.6 4a97J-4twfA: 33.7	4a97F-4twfA: 99.35 4a97J-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_G_ZPCG1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 12	PHE A 19 TYR A 38 ARG A 91 MET A 93 ILE A 101	None	0.55A	4a97F-4twfA: 33.6 4a97G-4twfA: 33.8	4a97F-4twfA: 99.35 4a97G-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_H_ZPCH1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 8	PHE A 19 TYR A 38 VAL A 40 ARG A 91 MET A 93 ILE A 101	None	0.54A	4a97G-4twfA: 33.8	4a97G-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_H_ZPCH1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 8	PHE A 19 VAL A 40 ARG A 91 MET A 93 ASN A 103	None	0.94A	4a97G-4twfA: 33.8	4a97G-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_H_ZPCH1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 7	GLU A 77 ILE A 79 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.45A	4a97H-4twfA: 33.9	4a97H-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_H_ZPCH1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 7	GLU A 131 TYR A 175 VAL A 181 PHE A 188	BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) None BR7 A 401 (-3.9A)	1.06A	4a97H-4twfA: 33.9	4a97H-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_I_ZPCI1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 7	PHE A 19 TYR A 38 VAL A 40 ARG A 91 ILE A 101	None	0.46A	4a97H-4twfA: 33.9	4a97H-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_I_ZPCI1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 7	PHE A 19 VAL A 40 ARG A 91 ASN A 103	None	0.97A	4a97H-4twfA: 33.9	4a97H-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_I_ZPCI1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 6	GLU A 77 ILE A 79 PHE A 133 TYR A 175	BR7 A 401 ( 4.9A) None BR7 A 401 (-4.5A) BR7 A 401 (-3.9A)	0.49A	4a97I-4twfA: 33.9	4a97I-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_J_ZPCJ1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 8	PHE A 19 TYR A 38 VAL A 40 ARG A 91 MET A 93 ILE A 101	None	0.57A	4a97I-4twfA: 33.9	4a97I-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_J_ZPCJ1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 8	PHE A 19 VAL A 40 ARG A 91 MET A 93 ASN A 103	None	0.99A	4a97I-4twfA: 33.9	4a97I-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_J_ZPCJ1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 8	TYR A 38 ARG A 91 MET A 93 GLU A 150	None	0.78A	4a97I-4twfA: 33.9	4a97I-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A97_J_ZPCJ1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 5	GLU A 77 GLU A 131 PHE A 133 TYR A 175	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-4.5A) BR7 A 401 (-3.9A)	0.57A	4a97J-4twfA: 33.7	4a97J-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWD_A_377A401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 5	GLU A 77 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.32A	4twdA-4twfA: 34.7 4twdE-4twfA: 34.1	4twdA-4twfA: 100.00 4twdE-4twfA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWD_B_377B401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 5	GLU A 77 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.34A	4twdA-4twfA: 34.7 4twdB-4twfA: 34.0	4twdA-4twfA: 100.00 4twdB-4twfA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWD_F_377F401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 7	GLU A 77 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.31A	4twdF-4twfA: 34.3 4twdJ-4twfA: 33.8	4twdF-4twfA: 100.00 4twdJ-4twfA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWD_H_377H401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 6	GLU A 77 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.39A	4twdG-4twfA: 34.0 4twdH-4twfA: 34.3	4twdG-4twfA: 100.00 4twdH-4twfA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWD_H_377H402_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 5	GLU A 77 GLU A 131 TYR A 175 PHE A 188	BR7 A 401 ( 4.9A) BR7 A 401 (-4.1A) BR7 A 401 (-3.9A) BR7 A 401 (-3.9A)	0.35A	4twdH-4twfA: 34.3 4twdI-4twfA: 34.0	4twdH-4twfA: 100.00 4twdI-4twfA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WW7_A_ACTA305_0 (EKC/KEOPS COMPLEX SUBUNIT BUD32)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 6	LEU A 130 LEU A 128 GLU A 129 ASN A 80	None	0.88A	4ww7A-4twfA: undetectable	4ww7A-4twfA: 22.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_A_Z80A401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 11	ILE A 20 ILE A 23 ASP A 158 TRP A 160 ILE A 162 ALA A 197	None	0.66A	5lg3A-4twfA: 32.5	5lg3A-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_A_Z80A401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 11	ILE A 20 ILE A 23 PHE A 126 ASP A 158 TRP A 160 ALA A 197	None	0.49A	5lg3A-4twfA: 32.5	5lg3A-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_A_Z80A401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 11	ILE A 23 PHE A 126 GLU A 155 TRP A 160 ALA A 197	None	0.93A	5lg3A-4twfA: 32.5	5lg3A-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_B_Z80B401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 9	ILE A 23 PHE A 126 GLU A 155 ASP A 158 TRP A 160	None	0.76A	5lg3B-4twfA: 32.4	5lg3B-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_E_Z80E401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 12	ILE A 20 ILE A 23 ASP A 158 ILE A 162 ALA A 197	None	0.72A	5lg3E-4twfA: 32.6	5lg3E-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_E_Z80E401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 12	ILE A 20 ILE A 23 PHE A 126 ASN A 154 ASP A 158 ALA A 197	None	0.62A	5lg3E-4twfA: 32.6	5lg3E-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_F_Z80F401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 10	ILE A 20 ILE A 23 ASP A 158 TRP A 160 ILE A 162	None	0.72A	5lg3F-4twfA: 32.7	5lg3F-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_F_Z80F401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 10	ILE A 20 ILE A 23 PHE A 126 ASP A 158 TRP A 160	None	0.45A	5lg3F-4twfA: 32.7	5lg3F-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_G_Z80G401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 10	ILE A 20 ILE A 23 PHE A 126 ASP A 158 TRP A 160 ILE A 162	None	0.67A	5lg3G-4twfA: 32.6	5lg3G-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_H_Z80H401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 10	ILE A 20 ILE A 23 ASP A 158 TRP A 160 ILE A 162	None	0.71A	5lg3H-4twfA: 32.5	5lg3H-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_H_Z80H401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 10	ILE A 20 ILE A 23 PHE A 126 ASP A 158 TRP A 160	None	0.40A	5lg3H-4twfA: 32.5	5lg3H-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_I_Z80I401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	4 / 9	ILE A 23 PHE A 126 ASP A 158 TRP A 160	None	0.45A	5lg3I-4twfA: 32.6	5lg3I-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_J_Z80J401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	5 / 12	ILE A 20 ILE A 23 ASP A 158 TRP A 160 ILE A 162	None	0.72A	5lg3J-4twfA: 32.4	5lg3J-4twfA: 99.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LG3_J_Z80J401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	4twf	CYS-LOOP LIGAND-GATED ION CHANNEL (Dickeya chrysanthemi)	6 / 12	ILE A 20 ILE A 23 PHE A 126 ASN A 154 ASP A 158 TRP A 160	None	0.66A	5lg3J-4twfA: 32.4	5lg3J-4twfA: 99.35

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MIC_A_DVAA6_0","GRAMICIDIN A","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",3,"ALA A  75;VAL A  73;TRP A  43","None","0.83A","1micA-4twfA:undetectable;1micB-4twfA:undetectable","1micA-4twfA:4.08;1micB-4twfA:4.08"],["2P16_A_GG2A298_2","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",3,"ARG A 231;GLU A 226;GLN A 298","None","1.04A","2p16A-4twfA:undetectable","2p16A-4twfA:19.17"],["2YOE_C_FL7C1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  39;VAL A  73;SER A  84;THR A  87;TYR A 102","None","0.42A","2yoeB-4twfA:34.3;2yoeC-4twfA:34.4","2yoeB-4twfA:99.35;2yoeC-4twfA:99.35"],["3IJD_A_C2FA314_0","UNCHARACTERIZED PROTEIN","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"VAL A  35;GLY A 108;LEU A 107;ILE A  39;ILE A 191","None","1.04A","3ijdA-4twfA:undetectable","3ijdA-4twfA:22.16"],["3RQW_A_ACHA323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.70A","3rqwA-4twfA:33.0;3rqwB-4twfA:33.0","3rqwA-4twfA:99.35;3rqwB-4twfA:99.35"],["3RQW_B_ACHB323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.68A","3rqwB-4twfA:33.0;3rqwC-4twfA:33.0","3rqwB-4twfA:99.35;3rqwC-4twfA:99.35"],["3RQW_C_ACHC323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.67A","3rqwC-4twfA:33.0;3rqwD-4twfA:33.0","3rqwC-4twfA:99.35;3rqwD-4twfA:99.35"],["3RQW_D_ACHD323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.67A","3rqwD-4twfA:33.0;3rqwE-4twfA:33.0","3rqwD-4twfA:99.35;3rqwE-4twfA:99.35"],["3RQW_E_ACHE323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.67A","3rqwA-4twfA:33.0;3rqwE-4twfA:33.0","3rqwA-4twfA:99.35;3rqwE-4twfA:99.35"],["3RQW_F_ACHF323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.68A","3rqwF-4twfA:33.0;3rqwG-4twfA:33.0","3rqwF-4twfA:99.35;3rqwG-4twfA:99.35"],["3RQW_G_ACHG323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.67A","3rqwG-4twfA:33.0;3rqwH-4twfA:33.0","3rqwG-4twfA:99.35;3rqwH-4twfA:99.35"],["3RQW_H_ACHH323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.66A","3rqwH-4twfA:33.0;3rqwI-4twfA:33.0","3rqwH-4twfA:99.35;3rqwI-4twfA:99.35"],["3RQW_I_ACHI323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"ILE A  79;GLU A 131;TYR A 175;PHE A 188","None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.60A","3rqwI-4twfA:33.0;3rqwJ-4twfA:33.0","3rqwI-4twfA:99.35;3rqwJ-4twfA:99.35"],["3RQW_J_ACHJ323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.68A","3rqwF-4twfA:33.0;3rqwJ-4twfA:33.0","3rqwF-4twfA:99.35;3rqwJ-4twfA:99.35"],["3U7S_A_017A201_2","POL POLYPROTEIN;POL POLYPROTEIN","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ALA A 104;ILE A  63;ILE A 101;PRO A  74;LEU A  76","None","1.20A","3u7sB-4twfA:undetectable","3u7sB-4twfA:14.33"],["4A97_A_ZPCA1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;PHE A 133;TYR A 175","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-4.5A);BR7 A 401 (-3.9A)","0.40A","4a97A-4twfA:33.7","4a97A-4twfA:99.35"],["4A97_A_ZPCA1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"ILE A  79;GLU A 131;TYR A 175;VAL A 181","None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);None","1.10A","4a97A-4twfA:33.7","4a97A-4twfA:99.35"],["4A97_A_ZPCA1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;TYR A  38;VAL A  40;ARG A  91;ILE A 101","None","0.48A","4a97E-4twfA:33.7","4a97E-4twfA:99.35"],["4A97_A_ZPCA1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"PHE A  19;VAL A  40;ARG A  91;ASN A 103","None","0.91A","4a97E-4twfA:33.7","4a97E-4twfA:99.35"],["4A97_A_ZPCA1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"TYR A  38;VAL A  40;ARG A  91;GLU A 150","None","0.72A","4a97E-4twfA:33.7","4a97E-4twfA:99.35"],["4A97_D_ZPCD1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"PHE A  19;TYR A  38;VAL A  40;ARG A  91;MET A  93;ILE A 101","None","0.55A","4a97C-4twfA:33.8","4a97C-4twfA:99.35"],["4A97_D_ZPCD1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;VAL A  40;ARG A  91;MET A  93;ASN A 103","None","0.90A","4a97C-4twfA:33.8","4a97C-4twfA:99.35"],["4A97_D_ZPCD1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;PHE A 133;TYR A 175","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-4.5A);BR7 A 401 (-3.9A)","0.54A","4a97D-4twfA:33.6","4a97D-4twfA:99.35"],["4A97_E_ZPCE1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"PHE A  19;TYR A  38;VAL A  40;ARG A  91;MET A  93;ILE A 101","None","0.45A","4a97D-4twfA:33.6","4a97D-4twfA:99.35"],["4A97_E_ZPCE1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;VAL A  40;ARG A  91;MET A  93;ASN A 103","None","0.85A","4a97D-4twfA:33.6","4a97D-4twfA:99.35"],["4A97_E_ZPCE1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"TYR A  38;ARG A  91;MET A  93;GLU A 150","None","0.91A","4a97D-4twfA:33.6","4a97D-4twfA:99.35"],["4A97_E_ZPCE1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A 131;PHE A 133;TYR A 175;PHE A 188","BR7 A 401 (-4.1A);BR7 A 401 (-4.5A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.55A","4a97E-4twfA:33.7","4a97E-4twfA:99.35"],["4A97_F_ZPCF1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;TYR A  38;ARG A  91;MET A  93;ILE A 101","None","0.49A","4a97F-4twfA:33.6;4a97J-4twfA:33.7","4a97F-4twfA:99.35;4a97J-4twfA:99.35"],["4A97_G_ZPCG1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;TYR A  38;ARG A  91;MET A  93;ILE A 101","None","0.55A","4a97F-4twfA:33.6;4a97G-4twfA:33.8","4a97F-4twfA:99.35;4a97G-4twfA:99.35"],["4A97_H_ZPCH1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"PHE A  19;TYR A  38;VAL A  40;ARG A  91;MET A  93;ILE A 101","None","0.54A","4a97G-4twfA:33.8","4a97G-4twfA:99.35"],["4A97_H_ZPCH1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;VAL A  40;ARG A  91;MET A  93;ASN A 103","None","0.94A","4a97G-4twfA:33.8","4a97G-4twfA:99.35"],["4A97_H_ZPCH1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"GLU A  77;ILE A  79;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.45A","4a97H-4twfA:33.9","4a97H-4twfA:99.35"],["4A97_H_ZPCH1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A 131;TYR A 175;VAL A 181;PHE A 188","BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);None;BR7 A 401 (-3.9A)","1.06A","4a97H-4twfA:33.9","4a97H-4twfA:99.35"],["4A97_I_ZPCI1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;TYR A  38;VAL A  40;ARG A  91;ILE A 101","None","0.46A","4a97H-4twfA:33.9","4a97H-4twfA:99.35"],["4A97_I_ZPCI1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"PHE A  19;VAL A  40;ARG A  91;ASN A 103","None","0.97A","4a97H-4twfA:33.9","4a97H-4twfA:99.35"],["4A97_I_ZPCI1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;ILE A  79;PHE A 133;TYR A 175","BR7 A 401 ( 4.9A);None;BR7 A 401 (-4.5A);BR7 A 401 (-3.9A)","0.49A","4a97I-4twfA:33.9","4a97I-4twfA:99.35"],["4A97_J_ZPCJ1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"PHE A  19;TYR A  38;VAL A  40;ARG A  91;MET A  93;ILE A 101","None","0.57A","4a97I-4twfA:33.9","4a97I-4twfA:99.35"],["4A97_J_ZPCJ1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"PHE A  19;VAL A  40;ARG A  91;MET A  93;ASN A 103","None","0.99A","4a97I-4twfA:33.9","4a97I-4twfA:99.35"],["4A97_J_ZPCJ1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"TYR A  38;ARG A  91;MET A  93;GLU A 150","None","0.78A","4a97I-4twfA:33.9","4a97I-4twfA:99.35"],["4A97_J_ZPCJ1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;PHE A 133;TYR A 175","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-4.5A);BR7 A 401 (-3.9A)","0.57A","4a97J-4twfA:33.7","4a97J-4twfA:99.35"],["4TWD_A_377A401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.32A","4twdA-4twfA:34.7;4twdE-4twfA:34.1","4twdA-4twfA:100.00;4twdE-4twfA:100.00"],["4TWD_B_377B401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.34A","4twdA-4twfA:34.7;4twdB-4twfA:34.0","4twdA-4twfA:100.00;4twdB-4twfA:100.00"],["4TWD_F_377F401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.31A","4twdF-4twfA:34.3;4twdJ-4twfA:33.8","4twdF-4twfA:100.00;4twdJ-4twfA:100.00"],["4TWD_H_377H401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.39A","4twdG-4twfA:34.0;4twdH-4twfA:34.3","4twdG-4twfA:100.00;4twdH-4twfA:100.00"],["4TWD_H_377H402_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"GLU A  77;GLU A 131;TYR A 175;PHE A 188","BR7 A 401 ( 4.9A);BR7 A 401 (-4.1A);BR7 A 401 (-3.9A);BR7 A 401 (-3.9A)","0.35A","4twdH-4twfA:34.3;4twdI-4twfA:34.0","4twdH-4twfA:100.00;4twdI-4twfA:100.00"],["4WW7_A_ACTA305_0","EKC\/KEOPS COMPLEX SUBUNIT BUD32","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"LEU A 130;LEU A 128;GLU A 129;ASN A  80","None","0.88A","4ww7A-4twfA:undetectable","4ww7A-4twfA:22.19"],["5LG3_A_Z80A401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"ILE A  20;ILE A  23;ASP A 158;TRP A 160;ILE A 162;ALA A 197","None","0.66A","5lg3A-4twfA:32.5","5lg3A-4twfA:99.35"],["5LG3_A_Z80A401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"ILE A  20;ILE A  23;PHE A 126;ASP A 158;TRP A 160;ALA A 197","None","0.49A","5lg3A-4twfA:32.5","5lg3A-4twfA:99.35"],["5LG3_A_Z80A401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  23;PHE A 126;GLU A 155;TRP A 160;ALA A 197","None","0.93A","5lg3A-4twfA:32.5","5lg3A-4twfA:99.35"],["5LG3_B_Z80B401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  23;PHE A 126;GLU A 155;ASP A 158;TRP A 160","None","0.76A","5lg3B-4twfA:32.4","5lg3B-4twfA:99.35"],["5LG3_E_Z80E401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  20;ILE A  23;ASP A 158;ILE A 162;ALA A 197","None","0.72A","5lg3E-4twfA:32.6","5lg3E-4twfA:99.35"],["5LG3_E_Z80E401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"ILE A  20;ILE A  23;PHE A 126;ASN A 154;ASP A 158;ALA A 197","None","0.62A","5lg3E-4twfA:32.6","5lg3E-4twfA:99.35"],["5LG3_F_Z80F401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  20;ILE A  23;ASP A 158;TRP A 160;ILE A 162","None","0.72A","5lg3F-4twfA:32.7","5lg3F-4twfA:99.35"],["5LG3_F_Z80F401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  20;ILE A  23;PHE A 126;ASP A 158;TRP A 160","None","0.45A","5lg3F-4twfA:32.7","5lg3F-4twfA:99.35"],["5LG3_G_Z80G401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"ILE A  20;ILE A  23;PHE A 126;ASP A 158;TRP A 160;ILE A 162","None","0.67A","5lg3G-4twfA:32.6","5lg3G-4twfA:99.35"],["5LG3_H_Z80H401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  20;ILE A  23;ASP A 158;TRP A 160;ILE A 162","None","0.71A","5lg3H-4twfA:32.5","5lg3H-4twfA:99.35"],["5LG3_H_Z80H401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  20;ILE A  23;PHE A 126;ASP A 158;TRP A 160","None","0.40A","5lg3H-4twfA:32.5","5lg3H-4twfA:99.35"],["5LG3_I_Z80I401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",4,"ILE A  23;PHE A 126;ASP A 158;TRP A 160","None","0.45A","5lg3I-4twfA:32.6","5lg3I-4twfA:99.35"],["5LG3_J_Z80J401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",5,"ILE A  20;ILE A  23;ASP A 158;TRP A 160;ILE A 162","None","0.72A","5lg3J-4twfA:32.4","5lg3J-4twfA:99.35"],["5LG3_J_Z80J401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","4twf","CYS-LOOP LIGAND-GATED ION CHANNEL","Dickeya chrysanthemi",6,"ILE A  20;ILE A  23;PHE A 126;ASN A 154;ASP A 158;TRP A 160","None","0.66A","5lg3J-4twfA:32.4","5lg3J-4twfA:99.35"]]